CN101422557A - Medicine for treating colitis - Google Patents
Medicine for treating colitis Download PDFInfo
- Publication number
- CN101422557A CN101422557A CNA2007101577270A CN200710157727A CN101422557A CN 101422557 A CN101422557 A CN 101422557A CN A2007101577270 A CNA2007101577270 A CN A2007101577270A CN 200710157727 A CN200710157727 A CN 200710157727A CN 101422557 A CN101422557 A CN 101422557A
- Authority
- CN
- China
- Prior art keywords
- gram
- medicine
- grams
- radix
- poria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating colitis, which belongs to traditional Chinese medical powders for treating chronic colitis. The invention provides a traditional Chinese medicament with reliable effects, wide indication, no side effects and low price to solve the problems of not ideal curative effects and high recurrence rate of the existing medicaments for treating chronic colitis. The components of the medicament are as follows: astragalus: 80 to 120g, glycyrrhiza: 30 to 40g, white peony roots: 30 to 40g, aokai: 20 to 30g, zhebei: 20 to 30g, cuttlebone:30 to 40g, poria: 30 to 40g, and prepared rhizoma corydalis: 30 to 40g.
Description
Technical field:
The invention belongs to the Chinese powder medicine of treatment chronic colitis.
Background technology:
Chronic colitis, Anaphylaxis enteritis, irritable bowel syndrome and diarrhoea are common clinical, frequently-occurring disease, this disease state of an illness complexity, and medical circle is not clear fully as yet to its pathogenic factor at present.Clinical commonly used drug, as: Spleen Invigorating and Intestine Tonifying Pill, GUBEN YICHANG PIAN etc., curative effect is unsatisfactory, and the relapse rate height, and late result is poor.Therefore, lack effective Therapeutic Method and medicine, classified as one of 14 kinds of refractory diseases by World Health Organization (WHO).
Summary of the invention:
The present invention solves the problem that curative effect of medication is undesirable, relapse rate is high of treatment chronic colitis at present, provides a kind of curative effect reliable, and indication is wide, has no side effect, cheap Chinese medicine.
The present invention adopts following technical scheme: component of the present invention is: the Radix Astragali 80-120 grams, Radix Glycyrrhizae 30-40 grams, the Radix Paeoniae Alba 30-40 grams, blue or green shellfish 20-30 grams, Bulbus Fritillariae Thunbergii 20-30 grams, Endoconcha Sepiae 30-40 grams, Poria 30-40 grams, Rhizoma Corydalis (processed) 30-40 grams.
The screening of above-mentioned medicine is clean, pulverizes, through 100 mesh sieve mix homogeneously, and packing packages spare.
This medicine is based on motherland's theory of medicine, is foundation with modern science to the current research of Chinese medicine, its reasonable recipe, and prescription is unique.Reuse Radix Astragali holder skin ulcer granulation promoting in this medicine, strengthening the body resistance; The Radix Paeoniae Alba, Rhizoma Corydalis (processed) nourishing blood to suppress the hyperactive liver regulating QI to relieve pain; Radix Glycyrrhizae, Poria invigorating spleen to remove dampness; Skin ulcer is held back in Bulbus Fritillariae Thunbergii, Endoconcha Sepiae lung heat clearing; Full medicine does not have antiinflammatory antidiarrheal simply, but shows the merit of antiinflammatory stopping leak.
Beneficial effect of the present invention:
One, curative effect is reliable, the cure rate height:
This medicine is used 5 years in my institute, during through revising repeatedly, clinical verification is now finalized the design.There are 1000 many cases patients to use this medicine over 5 years, according to clinical statistics effective percentage 95%, cure rate 80%.Based on oral powder, be aided with the external coloclysis individually, one time 5 gram, 2 times on the one, one month is a course of treatment, generally takes 2-3 courses of treatment, special circumstances are decided on the state of an illness.
Two, strengthening the body resistance has no side effect:
The used Chinese medicine of this medicine is Chinese medicine, have no side effect: reuse Radix Astragali strengthening the body resistance in this medicine, the QI invigorating granulation promoting, Poria, Radix Glycyrrhizae invigorating spleen to remove dampness, can remove symptoms such as stomachache, diarrhoea, bloody purulent stool effectively after the patient takes medicine, and improve immunocompetence, improve General Symptoms, stable disease, more the back is difficult for recurrence.
Three, the property of medicine is gentle, and indication is wide:
This medicine often course of disease is very long, state of an illness complexity, and deficient and excessive syndromes appearing together, cold and heat are staggered, for clinician's medication brings very big difficulty.Make a general survey of this medicine, cold not hot not dry, the property of medicine is comparatively gentle; Though used cold and cool blue or green shellfish, there is the Radix Astragali that is several times as much as it to restrict the cold and cool of blue or green shellfish, the property that the dry Rhizoma Corydalis (processed) of gas is held back with the acid of the Radix Paeoniae Alba is received it, makes all medicine property of medicine in this medicine gentle; Its subject range is extensive, no matter be asthenic cold type or excess-heat type, and damp-heat type or damp abundance due to splenic asthenia type, this medicine can both be suitable for, and is that multiple disease type one side transfers.
Four, make simply, cheap:
This medicine is a Chinese medicine powder, and its processing technology is simple, and it is comparatively convenient to take, and is easy to preserve, and is cheap, and tens yuan of courses of treatment, for the chronic, this is a very big advantage.
The specific embodiment:
Embodiment 1:
The Radix Astragali 80 grams, Radix Glycyrrhizae 30 grams, the Radix Paeoniae Alba 30 grams, blue or green shellfish 20 grams, Bulbus Fritillariae Thunbergii 20 grams, Endoconcha Sepiae 30 grams, Poria 30 grams, Rhizoma Corydalis (processed) 30 grams.
Embodiment 2:
The Radix Astragali 90 grams, Radix Glycyrrhizae 33 grams, the Radix Paeoniae Alba 33 grams, blue or green shellfish 22 grams, Bulbus Fritillariae Thunbergii 22 grams, Endoconcha Sepiae 33 grams, Poria 33 grams, Rhizoma Corydalis (processed) 32 grams.
Embodiment 3:
The Radix Astragali 100 grams, Radix Glycyrrhizae 40 grams, the Radix Paeoniae Alba 40 grams, blue or green shellfish 30 grams, Bulbus Fritillariae Thunbergii 30 grams, Endoconcha Sepiae 40 grams, Poria 40 grams, Rhizoma Corydalis (processed) 40 grams.
Claims (4)
1, the medicine of treatment colitis is characterized in that the Radix Astragali (80-120 gram), Radix Glycyrrhizae (30-40 gram), the Radix Paeoniae Alba (30-40 gram), blue or green shellfish (20-30 gram), Bulbus Fritillariae Thunbergii (20-30 gram), Endoconcha Sepiae (30-40 gram), Poria (30-40 gram), Rhizoma Corydalis (processed) (30-40 gram).
2, the medicine of treatment colitis according to claim 1 is characterized in that the Radix Astragali (80 gram), Radix Glycyrrhizae (30 gram), the Radix Paeoniae Alba (30 gram), blue or green shellfish (20 gram), Bulbus Fritillariae Thunbergii (20 gram), Endoconcha Sepiae (30 gram), Poria (30 gram), Rhizoma Corydalis (processed) (30 gram).
3, the medicine of treatment colitis according to claim 1 is characterized in that the Radix Astragali (90 gram), Radix Glycyrrhizae (33 gram), the Radix Paeoniae Alba (33 gram), blue or green shellfish (22 gram), Bulbus Fritillariae Thunbergii (22 gram), Endoconcha Sepiae (33 gram), Poria (33 gram), Rhizoma Corydalis (processed) (32 gram).
4, the medicine of treatment colitis according to claim 1 is characterized in that the Radix Astragali (100 gram), Radix Glycyrrhizae (40 gram), the Radix Paeoniae Alba (40 gram), blue or green shellfish (30 gram), Bulbus Fritillariae Thunbergii (30 gram), Endoconcha Sepiae (40 gram), Poria (40 gram), Rhizoma Corydalis (processed) (40 gram).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101577270A CN101422557A (en) | 2007-10-29 | 2007-10-29 | Medicine for treating colitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101577270A CN101422557A (en) | 2007-10-29 | 2007-10-29 | Medicine for treating colitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101422557A true CN101422557A (en) | 2009-05-06 |
Family
ID=40613588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101577270A Pending CN101422557A (en) | 2007-10-29 | 2007-10-29 | Medicine for treating colitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101422557A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103860844A (en) * | 2014-03-31 | 2014-06-18 | 袁志贤 | Traditional Chinese medicine preparation for treating chronic colitis and preparation method thereof |
-
2007
- 2007-10-29 CN CNA2007101577270A patent/CN101422557A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103860844A (en) * | 2014-03-31 | 2014-06-18 | 袁志贤 | Traditional Chinese medicine preparation for treating chronic colitis and preparation method thereof |
| CN103860844B (en) * | 2014-03-31 | 2016-03-02 | 袁志贤 | A kind of Chinese medicine preparation for the treatment of chronic colitis and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102133378A (en) | Medicament for treating breast cancer | |
| CN101327307A (en) | Medicament for treating cancer and preparation method | |
| CN101954052B (en) | Traditional Chinese medicine for treating cancers and preparation method thereof | |
| CN101708237B (en) | Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof | |
| CN103550719B (en) | A kind of Chinese medicine composition for the treatment of nasopharyngeal carcinoma | |
| CN101485803B (en) | Chinese medicinal composition for treating menoxenia and dysmenorrhea | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN103463583A (en) | Gastrointestinal disease treatment Chinese herbal | |
| CN102698098A (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN102698128A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN101954022B (en) | Chinese medicinal composition for treating lung cancer | |
| CN101422557A (en) | Medicine for treating colitis | |
| CN101549138B (en) | Acne treating Chinese medicine preparation and method of producing the same | |
| CN104436121B (en) | It is a kind of to treat irregular menstruation, small distention and fullness in the abdomen, the medicine to fail to be impregnated for a long time | |
| CN102698131A (en) | Capsule for treating diabetes mellitus | |
| CN102441137A (en) | Chinese medicine composition for resisting tumour | |
| CN101485823B (en) | Medicament for treating lung cancer and preparation method thereof | |
| CN102205031B (en) | Traditional Chinese medicine for treating male sterility | |
| CN1273172C (en) | Medicine for treating chronic colonitis | |
| CN111588757A (en) | Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease in stable phase and preparation method thereof | |
| CN104042887A (en) | Compound medicine for treating pulmonary heart disease and preparation method and application thereof | |
| CN101422511A (en) | Medicine for treating ulcerative colitis | |
| CN102824461A (en) | Medicine for treating hypertension and preparation method thereof | |
| CN101822812A (en) | Medicament for treating pneumonia and preparation method thereof | |
| CN1318073C (en) | Chinese medicine compound preparation for treating lung cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Fang Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
| C06 | Publication | ||
| PB01 | Publication | ||
| DD01 | Delivery of document by public notice |
Addressee: Liu Fang Document name: Notification of before Expiration of Request of Examination as to Substance |
|
| DD01 | Delivery of document by public notice |
Addressee: Liu Fang Document name: Notification that Application Deemed to be Withdrawn |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090506 |